Visualising disease progression on multiple variables with vector plots and path plots

BMC Medical Research Methodology

Volumn 9, Issue 1, 2009, Pages

  Lazic, Stanley E ^a,b   Mason, Sarah L ^b   Michell, Andrew W ^c   Barker, Roger A ^b,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIVARIATE ANALYSIS; DATA ANALYSIS; DISEASE COURSE; EXPLORATORY RESEARCH; HUMAN; HUNTINGTON CHOREA; INFORMATION PROCESSING; LONGITUDINAL STUDY; QUANTITATIVE ANALYSIS; STATISTICS; FEMALE; MALE; METHODOLOGY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY; REPRODUCIBILITY; STATISTICAL MODEL; TASK PERFORMANCE; TIME;

DISEASE PROGRESSION; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); REPRODUCIBILITY OF RESULTS; TASK PERFORMANCE AND ANALYSIS; TIME FACTORS;

EID: 67650682545     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-9-32     Document Type: Article

References (42)

1. Analysis of serial measurements in medical research. JN Matthews DG Altman MJ Campbell P Royston, BMJ 1990 300 6719 230 235 2106931 10.1136/bmj.300.6719.230 (Pubitemid 20045528)
2. JC Pinheiro DM Bates, Mixed-Effects Models in S and S-Plus London: Springer 2000
3. JO Ramsay BW Silverman, Applied Functional Data Analysis: Methods and Case Studies New York, NY: Springer 2002
4. JO Ramsay BW Silverman, Functional Data Analysis New York, NY: Springer 2 2006
5. T Hastie R Tibshirani J Friedman, The Elements of Statistical Learning New York: Springer 2001
6. B Everitt, An R and S-Plus Companion to Multivariate Analysis London: Springer 2005
7. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. N Pavese A Gerhard YF Tai AK Ho F Turkheimer RA Barker DJ Brooks P Piccini, Neurology 2006 66 11 1638 1643 10.1212/01.wnl.0000222734. 56412.17 16769933
8. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. I Reuter YF Tai N Pavese KR Chaudhuri S Mason CE Polkey C Clough DJ Brooks RA Barker P Piccini, J Neurol Neurosurg Psychiatry 2008 79 8 948 951 10.1136/jnnp.2007.142380 18356253
9. Hypothalamic involvement in Huntington's disease: an in vivo PET study. M Politis N Pavese YF Tai SJ Tabrizi RA Barker P Piccini, Brain 2008 18829696
10. JW Tukey, Exploratory Data Analysis Addison-Wesley 1977
11. WS Cleveland, Visualizing Data Summit, NJ: Hobart Press 1993
12. WS Cleveland, The Elements of Graphing Data New Jersey: Hobart Press, revised edition 1994
13. D Cook DF Swayne, Interactive and Dynamic Graphics for Data Analysis New York, NY: Springer 2007 http://www.ggobi.org
14. U Fayyad GG Grinstein A Wierse Eds, Information Visualization in Data Mining and Knowledge Discovery London: Academic Press 2002
15. Hand tapping: a simple, reproducible, objective marker of motor dysfunction in Huntington's disease. AW Michell AO Goodman AH Silva SE Lazic AJ Morton RA Barker, J Neurol 2008 255 8 1145 1152 10.1007/s00415-008-0859-x 18465109
16. MS Gazzaniga RB Ivry GR Mangun, Cognitive Neuroscience: The Biology of the Mind New York, NY: W. W. Norton & Company 1998
17. Visual graphical analysis: a technique to investigate symptom trajectories over time. CG Brown DB McGuire SL Beck DE Peterson KH Mooney, Nurs Res 2007 56 3 195 201 10.1097/01.NNR.0000270029.82736.5a 17495575
18. Biomarkers and Parkinson's disease. AW Michell SJG Lewis T Foltynie RA Barker, Brain 2004 127 Pt 8 1693 1705 10.1093/brain/awh198 15215212
19. The molecular biology of Huntington's disease. LW Ho J Carmichael J Swartz A Wyttenbach J Rankin DC Rubinsztein, Psychol Med 2001 31 3 14 10.1017/S0033291799002871 11200958
20. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord 1996 11 2 136 142 10.1002/mds.870110204 8684382
21. NEST-UK: Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. AE Rosser RA Barker T Harrower C Watts M Farrington AK Ho RM Burnstein DK Menon JH Gillard J Pickard SB Dunnett, J Neurol Neurosurg Psychiatry 2002 73 6 678 685 12438470 10.1136/jnnp.73.6.678
22. R: a language for data analysis and graphics. R Ihaka R Gentleman, J Comput Graph Stat 1996 5 299 314 10.2307/1390807
23. R Development Core Team, R: A Language and Environment for Statistical Computing R Foundation for Statistical Computing, Vienna, Austria 2008 http://www.r-project.org
24. WN Venables BD Ripley, Modern Applied Statistics with S New York: Springer 4 2002
25. MJ Crawley, The R Book Chichester: Wiley 2007
26. P Murrell, R Graphics Boca Raton, FL: Chapman & Hall/CRC 2005
27. ER Tufte, The Visual Display of Quantitative Information Cheshire, CT: Graphics Press 2 2001
28. On the relation between initial value and slope. K Byth DR Cox, Biostatistics 2005 6 3 395 403 10.1093/biostatistics/kxi017 15831582
29. D Adler D Murdoch, rgl: 3D visualization device system (OpenGL) 2008 http://rgl.neoscientists.org
30. L Wilkinson, The Grammar of Graphics New York, NY: Springer 2 2005
31. The heterogeneity of idiopathic Parkinson's disease. T Foltynie C Brayne RA Barker, J Neurol 2002 249 2 138 145 10.1007/PL00007856 11985378 (Pubitemid 34143467)
32. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. SJG Lewis T Foltynie AD Blackwell TW Robbins AM Owen RA Barker, J Neurol Neurosurg Psychiatry 2005 76 3 343 348 15716523 10.1136/jnnp.2003.033530
33. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. A Goris CH Williams-Gray GR Clark T Foltynie SJG Lewis J Brown M Ban MG Spillantini A Compston DJ Burn PF Chinnery RA Barker SJ Sawcer, Ann Neurol 2007 62 2 145 153 10.1002/ana.21192 17683088
34. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. CH Williams-Gray T Foltynie CEG Brayne TW Robbins RA Barker, Brain 2007 130 Pt 7 1787 1798 10.1093/brain/awm111 17535834
35. The use of quantitative oculometry in the assessment of Huntington's disease. FR Ali AW Michell RA Barker RHS Carpenter, Exp Brain Res 2006 169 2 237 245 10.1007/s00221-005-0143-6 16273398
36. Olfactory abnormalities in Huntington's disease: decreased plasticity in the primary olfactory cortex of R6/1 transgenic mice and reduced olfactory discrimination in patients. SE Lazic AO Goodman HE Grote C Blakemore AJ Morton AJ Hannan A van Dellen RA Barker, Brain Res 2007 1151 219 226 10.1016/j.brainres.2007.03.018 17400200
37. Increased rate of whole-brain atrophy over 6 months in early Huntington disease. SMD Henley C Frost DG MacManus TT Warner NC Fox SJ Tabrizi, Neurology 2006 67 4 694 696 10.1212/01.wnl.0000230149.36635.c8 16924028
38. Statistical methods for assessing agreement between two methods of clinical measurement. JM Bland DG Altman, Lancet 1986 1 8476 307 310 2868172 (Pubitemid 16134762)
39. Measuring agreement in method comparison studies. JM Bland DG Altman, Stat Methods Med Res 1999 8 2 135 160 10.1191/096228099673819272 10501650
40. Applying the right statistics: analyses of measurement studies. JM Bland DG Altman, Ultrasound Obstet Gynecol 2003 22 85 93 10.1002/uog.122 12858311
41. Agreement between methods of measurement with multiple observations per individual. JM Bland DG Altman, J Biopharm Stat 2007 17 4 571 582 10.1080/10543400701329422 17613642
42. R Pahwa KE Lyons WC Koller, Handbook of Parkinson's Disease, Differential Diagnosis of Parkinsonism New York, NY: Informa Health Care, Sethi KD, 3 2003 chap 3 43 70